Navigation Links
Drug combination acts against aggressive chronic lymphocytic leukemia
Date:12/10/2012

increase in leukemia cells in the blood due to release of CLL cells from the tissues (lymph glands) into the blood stream. Rituximab, a well-established antibody, was added to capture the CLL cells in the blood and thereby accelerate and improve response.

"When we looked at how well the high-risk patients were doing on ibrutinib - even though it was a small number - we saw a great opportunity to find out if combining the two drugs would have a positive impact on these patients," Burger said.

Combination tolerated well

Forty patients with high-risk CLL were enrolled in the study earlier this year. They received:

  • Daily oral doses of 420 mg ibrutinib throughout treatment
  • Weekly infusions of rituximab (375 mg/m2) weeks one through four
  • Monthly rituximab infusions for the next five months

At a median follow up of four months, 38 patients remained on ibrutinib therapy without disease progression. One patient died from an unrelated infectious complication, and one patient discontinued therapy due to oral ulcers.

Preliminary results: 85 percent response rate

Of 20 patients evaluated for early response at three months, 17 achieved partial remission for an overall response rate of 85%. Three achieved partial remission with persistent lymphocytosis.

Interestingly, lymphocytosis peaked earlier and the duration was shorter than with ibrutinib alone.

Treatment was well tolerated, with 13 cases of grade 3 or grade 4 toxicities, including neutropenia, fatigue, pneumonia, insomnia and bone aches. Most side effects were unrelated and transient. Many patients reported improved overall health and quality of life after three cycles of treatment.

"Although this study has a short follow-up time, we are encouraged by the fact that the vast majority of patients are responding and are able to continue on treatment, Burger said.

Development of ibrutinib for CLL
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
2. Combination treatment may improve survival of breast cancer patients with brain metastases
3. Drug combination against NRAS-mutant melanoma discovered
4. Combination peptide therapies might offer more effective, less toxic cancer treatment
5. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
6. BUSM in vitro study identifies potential combination therapy for breast cancer
7. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
8. Discovery suggests new combination therapy strategy for basal-like breast cancers
9. Cancer vaccine combination therapy shows survival benefit in breast cancer
10. Combination of 2 drugs reverses liver tumors
11. Immunotherapy for elderly cancer patients finds new promise in drug combination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug combination acts against aggressive chronic lymphocytic leukemia
(Date:8/27/2014)... Ticket Down is a dependable source for ... Stadium in Miami. The Brazilian national soccer team will ... at Sun Life Stadium in Miami Gardens, Florida. The ... the World Cup earlier this year when Brazil got the ... Brazilian Soccer Federation announced earlier this week that Neymar would ...
(Date:8/27/2014)... Connor Sports has produced six custom ... in Spain at the Barcelona, Bilbao, Gran Canaria, Granada, Madrid ... Venue Centre Partner since 1994 and Official Technical Supplier of ... bear the Connor Sports logo and tagline “Where Champions Play” ... ESPN broadcasts of the FIBA World Cup. , “Connor Sports ...
(Date:8/27/2014)... PA (PRWEB) August 27, 2014 What’s ... of this year’s 87th Annual Scripps National Spelling Bee? ... for a tour of internationally renowned Wills Eye Hospital.     ... like to be an ophthalmologist one day. , Wills ... eye surgery and the latest hi-tech visual diagnostic testing. ...
(Date:8/27/2014)... 2014 (HealthDay News) -- A new study finds that ... for seniors with sleep apnea. CPAP is widely ... a condition in which the airway relaxes and narrows ... leads to daytime drowsiness. CPAP keeps ... through a patient,s nose via a mask that is ...
(Date:8/27/2014)... each receive $100,000 in funding to launch pilot programs ... for patients served by community health centers. The program ... and is part of the group,s effort to reach ... over receiving regular screening for colorectal cancer by 2018. ... are: Port Royal, South Carolina; New Haven, Connecticut; and ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3
... To Reduce Losses, SPRINGFIELD, Ohio, March 31 ... based long term care, home care and,management company today ... Revenues for the year ended December 31, 2007 ... of $1,118,271. The improvement,was primarily due to increased occupancy ...
... card from The National,Committee for Quality Assurance (NCQA) ... products have passed with flying colors., In ... its members and noting improvements to the company,s ... of,Excellent - the highest level achievable., Medical ...
... primates points to possible weapon against human infection with ... Researchers have successfully tested several Ebola vaccines in monkeys ... vaccine for one of the world,s deadliest diseases. ... overlooked. We are seeing more and more naturally occurring ...
... required more procedures to reopen arteries, study found , , ... blockages in the left main coronary artery, percutaneous coronary ... may be a viable alternative to bypass surgery. , ... between PCI and surgery," Dr. Seung-Jung Park, senior author ...
... Gan has established that patients with a high blood pressure ... capable of pumping blood against this pressure. Further, the right ... Gan is the first Mosaic laureate to gain his doctorate. ... out into the cause of high blood pressure in the ...
... March 31 The Epilepsy,Foundation,s quick reaction to a ... raises awareness of the need for Web security for ... and those who,use its online forums for help, support, ... posted rapidly flashing images to cause,serious injury and harm. ...
Cached Medicine News:Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 2Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 3Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 4Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 5Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 6Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 7Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 8Health News:AdCare Health Systems, Inc. Reports Financial Results for 2007 9Health News:Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 2Health News:Researchers Successfully Test Ebola Vaccines 2Health News:Angioplasty Proves Reasonable Alternative to Bypass Surgery 2Health News:Epilepsy Foundation Takes Action Against Hackers 2
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
(Date:8/27/2014)... WOONSOCKET, R.I. , Aug. 27, 2014  CVS ... has entered into a new clinical affiliation with MedStar ... in Maryland and the ... access to high-quality, affordable health care services for patients. ... to have access to clinical support, medication counseling, chronic ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 ... Pharmaceutical Co., Ltd, ("Menovo") today announced they had entered ... pharmaceuticals, primarily targeting the United States ... and Menovo will jointly develop products for Amerigen to ... Menovo will be responsible for manufacturing API and finished ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
Link All-Poly acetabular cups for cement....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Medicine Products: